[Controversial expertise. The "Scientific Advisory Committee for Drug Safety" and its role in drug regulation in the Federal Republic of Germany, 1968-1976].
The article focuses on the "Scientific Advisory Committee for Drug Safety" of the Federal Ministry of Health. Highlighting the role this committee played in West Germany's policy on medicinal drugs, it shows how drug regulation during this period shifted from expert committees to a larger public consisting of media, pressure groups of alternative medicine and politicians.
Kessel
Nils
N
Institut de Recherches Interdisciplinaires sur les Sciences et la Technologie (IRIST EA 3424), Faculté de Médecine, Université Louis Pasteur, Strasbourg, Frankreich. nils.kessel@medecine.u-strasbg.fr
D026683:Advisory Committees / Q000266:history*; D000529:Complementary Therapies / Q000266:history*; D017277:Drug Approval / Q000266:history*; D064420:Drug-Related Side Effects and Adverse Reactions / Q000266:history*; D005858:Germany; D049673:History, 20th Century; D006801:Humans; D008402:Mass Media / Q000266:history*; D055553:Prescription Drugs / Q000266:history*; D011361:Professional Competence
D055553:Prescription Drugs